US2561352038
US2561352038
Dr. Reddy's Laboratories Ltd
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 10.4B EUR | 12.07B EUR | 11.53B EUR | 11.69B EUR |
Enterprise Value | 54.68B EUR | 72.82B EUR | 73.51B EUR | 60.76B EUR |
Valuation Multiples | ||||
Trailing P/E | 28.36x | 0.36x | 0.27x | 0.29x |
Forward P/E | 19.45x | -- | -- | -- |
Price to Sales | 0.03x | 0.04x | 0.03x | 0.04x |
Price to Book | 15.64x | 0.03x | 0.03x | 0.03x |
EV/Revenue | 0.17x | 0.22x | 0.22x | 0.23x |
EV/EBITDA | 1x | 1.12x | 0.93x | 0.9x |
Price to FCF (P/FCF) | -- | 1.31x | 0.63x | 0.87x |
EV/FCF | -- | 7.9x | 4.01x | 4.5x |
FCF Yield | -37.61% | 76.38% | 158.94% | 115.56% |